UCB S.A.
UCBJFOTCHealthcare● Active
$292.14
$-21.58(-6.88%)
Market Cap$55.6B
P/E Ratio—
52W High$345.39
52W Low$178.54
UCB S.A. (UCBJF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
UCBJF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 26, 2026EPS Actual
$7.59
Est. $5.83 · +30.2%
Revenue
$5.00B
Est. $4.94B · +1.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 26, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
UCBJF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $4.73 | — | — | — | $4.67B | — |
| ▲ Q1 FY2026 | Feb 26, 2026 | $5.83 | $7.59 | +30.2% | $5.00B | $4.94B | +1.1% |
| ▼ Q3 FY2025 | Jul 31, 2025 | $3.89 | $2.88 | -26.0% | $4.11B | $3.78B | +8.7% |
| ▲ Q1 FY2025 | Feb 27, 2025 | $2.68 | $4.56 | +70.2% | $3.48B | $3.18B | +9.3% |
| ▼ Q3 FY2024 | Jul 25, 2024 | $1.89 | $1.15 | -39.1% | $3.00B | $2.87B | +4.7% |
| ▼ Q1 FY2024 | Feb 28, 2024 | $1.48 | $0.18 | -88.1% | $2.93B | $2.81B | +4.3% |
| ▼ Q2 FY2023 | Jun 30, 2023 | $1.84 | $1.74 | -5.4% | $2.82B | $2.77B | +2.0% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $0.81 | $0.11 | -86.8% | $2.79B | $2.70B | +3.3% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$4.73
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$7.59
EPS Est.
$5.83
EPS Surpr.
+30.2%
Revenue
$5.00B
Q3 FY2025
Jul 31, 2025Miss
EPS Actual
$2.88
EPS Est.
$3.89
EPS Surpr.
-26.0%
Revenue
$4.11B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$4.56
EPS Est.
$2.68
EPS Surpr.
+70.2%
Revenue
$3.48B
Q3 FY2024
Jul 25, 2024Miss
EPS Actual
$1.15
EPS Est.
$1.89
EPS Surpr.
-39.1%
Revenue
$3.00B
Q1 FY2024
Feb 28, 2024Miss
EPS Actual
$0.18
EPS Est.
$1.48
EPS Surpr.
-88.1%
Revenue
$2.93B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
$1.74
EPS Est.
$1.84
EPS Surpr.
-5.4%
Revenue
$2.82B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
$0.11
EPS Est.
$0.81
EPS Surpr.
-86.8%
Revenue
$2.79B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $4.29 | $4.29 | $4.29 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $2.47 | $2.47 | $2.47 | 1 |
| Q2 FY2024 | $1.78 | $1.78 | $1.78 | 1 |
| Q4 FY2023 | $0.22 | $0.22 | $0.22 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $3.2B | $3.2B | $3.2B | 1 |
| Q3 FY2025 | $3.5B | $3.5B | $3.5B | 1 |
| Q2 FY2025 | $3.5B | $3.5B | $3.5B | 1 |
| Q4 FY2024 | $2.8B | $2.8B | $2.8B | 1 |
| Q2 FY2024 | $2.5B | $2.5B | $2.5B | 1 |
| Q4 FY2023 | $2.3B | $2.3B | $2.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 26, 2026 | +30.2% | $310.61 | $306.00 | -1.48% |
| ▼ Q3 FY2025 | Jul 31, 2025 | -26.0% | $219.79 | $219.79 | +0.00% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +70.2% | $192.00 | $192.00 | +0.00% |
| ▼ Q3 FY2024 | Jul 25, 2024 | -39.1% | $152.50 | $152.50 | +0.00% |
| ▼ Q1 FY2024 | Feb 28, 2024 | -88.1% | $102.00 | $110.35 | +8.19% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -5.4% | $86.66 | $86.66 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -86.8% | $80.40 | $80.40 | +0.00% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -16.7% | $85.60 | $85.60 | +0.00% |
Q1 FY2026-1.48%
Report Date
Feb 26, 2026
EPS Beat/Miss
+30.2%
Price Before
$310.61
Price After
$306.00
Q3 FY2025+0.00%
Report Date
Jul 31, 2025
EPS Beat/Miss
-26.0%
Price Before
$219.79
Price After
$219.79
Q1 FY2025+0.00%
Report Date
Feb 27, 2025
EPS Beat/Miss
+70.2%
Price Before
$192.00
Price After
$192.00
Q3 FY2024+0.00%
Report Date
Jul 25, 2024
EPS Beat/Miss
-39.1%
Price Before
$152.50
Price After
$152.50
Q1 FY2024+8.19%
Report Date
Feb 28, 2024
EPS Beat/Miss
-88.1%
Price Before
$102.00
Price After
$110.35
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
-5.4%
Price Before
$86.66
Price After
$86.66
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-86.8%
Price Before
$80.40
Price After
$80.40
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-16.7%
Price Before
$85.60
Price After
$85.60
Avg Beat Reaction-0.74%
Avg Miss Reaction+1.36%
Beat Rate2 / 8 quarters
Largest Move+8.19% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: UCBJF ends December
UCB S.A. (UCBJF) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $7.59 — beating the analyst consensus of $5.83 by +30.2%. The next UCBJF earnings date is expected around September 1, 2026.
Each quarter, investors track UCBJF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. UCBJF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
UCBJF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
UCBJF earnings · 5 questionsUCB S.A.'s next earnings report is expected around September 1, 2026. UCBJF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; UCBJF historically reports after market close (AMC).
UCBJF earnings datewhen is UCBJF earningsUCBJF next earnings datewhen does UCBJF report earningsUCBJF earnings calendar
▸ Source: FMP · UCB S.A. SEC filings · US GAAP · UCB S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026